PRIMARY STUDY

Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors

Key Findings:  These data suggest that the body’s own endocannabinoid 2-AG negatively modulates the inflammatory milieu of cancer cells in vitro (via CB1 and CB2 activation) thus potentially increasing proliferation, while AM281 (a CB1 inverse agonist) decreased cancer proliferation.

Type of Study:  Laboratory Study

Study Result:  Inconclusive

Study Location(s):  Italy

Year of Pub:  2015


Cannabinoids Studied:  AM-x Synthetic Cannabinoids, 2-Arachidonoyl Glycerol (2-AG)

Phytocannabinoid Source:  Not Applicable

Receptors Studied:  CB1, CB2

Ligands Studied:  Pro-inflammatory cytokines

Route of Administration:  In vitro



Link to study